Global 2023 - Players, Regions, Product Types, Application & Forecast Analysis
收藏theindustrystats.com2025-03-26 收录
下载链接：
https://theindustrystats.com/report/biotin-market/2865/?utm_source=google&utm_medium=datasets&utm_campaign=datasetsearch
下载链接
链接失效反馈官方服务：
资源简介：
Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period<table class='table'> <tr> <th>ATTRIBUTES</th> <th>DETAILS</th> </tr><tr> <td>STUDY PERIOD</td><td>2017-2030</td></tr><tr> <td>BASE YEAR</td><td>2023</td></tr><tr> <td>FORECAST PERIOD</td><td>2024-2030</td></tr><tr> <td>HISTORICAL PERIOD</td><td>2017-2022</td></tr><tr> <td>UNIT</td><td>VALUE (USD MILLION)</td></tr><tr> <td>KEY COMPANIES PROFILED</td><td>Zhejiang Medicine, SDM, Hegno, Shanghai Acebright, NUH, Anhui Tiger Biotech, Kexing Biochem, DSM</td></tr><tr> <td>SEGMENTS COVERED</td><td style='text-transform:capitalize;'>By Product Type - 1% Biotin, 2% Biotin, Pure Biotin (>98%), Other<br>By Application - Food, Pharma & Cosmetics, Animal Feed<br>By Sales Channels - Direct Channel, Distribution Channel<br>By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa</td></tr></table>
近几年来，产品市场规模呈上升趋势，预计在未来预测期内将显著增长。<table class='table'> <tr> <th>属性</th> <th>详细信息</th> </tr> <tr> <td>研究周期</td> <td>2017-2030</td> </tr> <tr> <td>基准年</td> <td>2023</td> </tr> <tr> <td>预测周期</td> <td>2024-2030</td> </tr> <tr> <td>历史周期</td> <td>2017-2022</td> </tr> <tr> <td>计量单位</td> <td>价值（亿美元）</td> </tr> <tr> <td>主要公司概况</td> <td>浙江医药，SDM，赫格诺，上海安赛bright，新加坡国立大学医院，安徽安泰生物技术，科兴生化，DSM</td> </tr> <tr> <td>涵盖的细分市场</td> <td style='text-transform:capitalize;'>按产品类型 - 1% 生物素，2% 生物素，纯生物素（>98%），其他<br>按应用 - 食品，药品与化妆品，动物饲料<br>按销售渠道 - 直接渠道，分销渠道<br>按地理区域 - 北美洲，欧洲，亚太地区，南美洲，中东及非洲</td> </tr> </table>
提供机构：
The Industry Stats Market Research
